Safety and efficacy of apixaban in patients with glomerulonephritis and nephrotic syndrome: a prospective longitudinal cohort study

Aim. Assessment of the efficacy and safety of apixaban in preventing thromboembolic complications in patients with nephrotic syndrome caused by primary glomerulonephritis. Materials and methods. We conducted a prospective longitudinal cohort study involving 125 patients with glomerulonephritis an...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	I. S. Mykhaloiko, R. I. Yatsyshyn, I. O. Dudar, O. I. Hotsaniuk, H. M. Kuryliv
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Zaporizhzhia State Medical and Pharmaceutical University 2025-03-01
סדרה:	Сучасні медичні технології
נושאים:	apixaban nephrotic syndrome glomerulonephritis thromboembolism anticoagulation warfarin bleeding complications
גישה מקוונת:	https://medtech.mphu.edu.ua/article/view/320766/315341
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!